¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chain initiation reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • induced reaction
    À¯¹ß¹ÝÀÀ
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ
  • interface reaction
    °æ°è¸é¹ÝÀÀ
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermicellar reaction
    ¹Ì¼¼¸£°£¹ÝÀÀ
  • Jarisch-Herxheimer reaction
    ¾ß¸®½´-Ç츣ũ½ºÇÏÀ̸ӹÝÀÀ
  • johnin reaction
    ¿ä´Ñ¹ÝÀÀ
  • labile oxidase reaction
    ºÒ¾ÈÁ¤»êÈ­È¿¼Ò¹ÝÀÀ
  • lengthening reaction
    1. ´ÃÀÓ¹ÝÀÀ, ½ÅÀå¹ÝÀÀ 2. ±Ù´ÃÀÓ¹ÝÀÀ
  • lepra reaction
    ³ªº´¹ÝÀÀ
  • lepromin reaction
    ·¹ÇÁ·Î¹Î¹ÝÀÀ
  • leukemoid reaction
    ¹éÇ÷º´¸ð¾ç¹ÝÀÀ
  • leukoerythroblastic reaction
    ¹éÀûÇ÷¸ð±¸¹ÝÀÀ
  • labyrinthine righting reaction
    ¹Ì·Î¹Ù·ÎÀâ±â¹ÝÀÀ
  • ligation reaction
    °áÂû¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ
  • immunologic reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
  • immunological reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
  • immunoprecipitin reaction
    ¸é¿ªÄ§Àü¹ÝÀÀ
  • indirect immunofluorescence reaction
    °£Á¢¸é¿ªÇü±¤¹ÝÀÀ
  • indophenol reaction
    (¢¡indophenol test) ÀεµÆä³î°Ë»ç
  • induced reaction
    À¯¹ß¹ÝÀÀ
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ, ÀúÁö¹ÝÀÀ
  • initial reaction
    Ãʱâ¹ÝÀÀ
  • interface reaction
    °è¸é¹ÝÀÀ
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermicellar reaction
    ¹Ì¼¼¸£°£¹ÝÀÀ
  • involutional depressive reaction
    °»³â±â¿ì¿ï¹ÝÀÀ
  • involutional paranoid reaction
    °»³â±âÆíÁý¹ÝÀÀ
  • involutional psychotic reaction
    °»³â±âÁ¤½Åº´¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • reaction isochore
    ¹ÝÀÀÇ׿ë½Ä(ÚãëëùöéÄãÒ).
  • reaction kinetics
    ¹ÝÀÀ¼Óµµ·Ð(ÚãëëáÜöôÖå).
  • reaction of identity
    ÀÏÄ¡¹ÝÀÀ
  • reaction of non-identity
    ºÒÀÏÄ¡¹ÝÀÀ
  • reaction of partial identity
    ºÎºÐÀÏÄ¡¹ÝÀÀ
  • reaction period
    ¹ÝÀÀ±â(ÚãëëÑ¢).
  • reaction sequence
    ¹ÝÀÀ¼ø¼­.
  • reaction substance
    ¹ÝÀÀ¹°Áú(ÚãëëÚªòõ).
  • reaction threshold
    ¹ÝÀÀ¿ªÄ¡(ÚãëëÚÊö·).
  • reaction time
    ¹ÝÀÀ½Ã(°£)(ÚãëëãÁÊà).
  • recurrent reaction
    Àç¹ß¹ÝÀÀ(î¢Û¡Úãëë).
  • red reaction
    ¹ßÀûÀÛ¿ë.
  • redox reaction
    »êȭȯ¿ø¹ÝÀÀ(ß«ûùü»êª Úãëë).
  • rejection reaction
    °ÅÀý(¹ÝÀÀ)(ËÞï¾Úãëë).
  • rejection reaction
    °ÅÀý(¹ÝÀÀ)(ËÞï¾Úãëë).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • cross reaction
    ±³Â÷¹ÝÀÀ(Îßó©Úãëë).
  • cross-reaction
    ±³Â÷¹ÝÀÀ
  • cross-reaction antigen
    ±³Â÷¹ÝÀÀÇ׿ø
  • cutaneous drug reaction
    ÇǺξàÁø
  • cutaneous reaction
    ÇǺΠ¹ÝÀÀ
  • cytotoxic reaction
    ¼¼Æ÷µ¶¼º¹ÝÀÀ.
  • cytotoxic reaction
    µ¶¼º¹ÝÀÀ.
  • cytotoxic reaction
    ¼¼Æ÷ µ¶¼º ¹ÝÀÀ
  • defensive reaction
    ¹æ¾îÀÛ¿ë(ÛÁåÝíÂéÄ)
  • deficient release reaction
    ¹æÃâ¹ÝÀÀ°áÇÌ.
  • delayed allergic reaction
    Áö¿¬¼º ¾Ë·¹¸£±â¹ÝÀÀ.
  • delayed allergic reaction
    Áö¿¬¼º ¾Ë·¹¸£±â¹ÝÀÀ
  • delayed cell-mediated reaction
    Áö¿¬Çü ¼¼Æ÷¸Å°³¹ÝÀÀ
  • delayed reaction
    Áö¿¬¹ÝÀÀ(òÀæÅÚãëë).
  • desmoid reaction
    Àδë¾ç¹ÝÀÀ(ìåÓáåÆÚãëë).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • pseudounimolecular reaction
    À§´ÜºÐÀÚ¹ÝÀÀ(êÊÓ¤ÝÂí­Úãëë)
  • Quellung reaction
  • rapid reaction
    ±Þ¹ÝÀÀ(ÐáÚãëë)
  • reaction center
    ¹ÝÀÀ Áß½É(Úãëëñéãý)
  • reaction coordinate
    ¹ÝÀÀÁÂÇ¥(Úãëëñ¨øö)
  • reaction kinetics
    ¹ÝÀÀ ¼Óµµ·Ð(ÚãëëáÜÓøÖå)
  • reaction mixture
    ¹ÝÀÀ È¥ÇÕ¹°(ÚãëëûèùêÚª)
  • reaction of identity
    µ¿Áú¼º ¹ÝÀÀ(ÔÒòõàõÚãëë)
  • reaction of nonidentity
    ÀÌÁú¼º ¹ÝÀÀ(ì¶òõàõÚãëë)
  • reaction of partial identity
    ºÎºÐ µ¿Áú¼º(Ý»ÝÂÔÒòõàõ) ¹ÝÀÀ(Úãëë)
  • reaction order
    ¹ÝÀÀÂ÷¼ø(Úãëëó­â÷)
  • reaction paper cheomatography
    ¹ÝÀÀ ¿©Áö(Úãëëæ¤òµ) Å©·Î¸¶Åä±×·¡ÇÇ
  • reaction rate
    ¹ÝÀÀ ¼Óµµ·Ð(ÚãëëáÜÓøÖå)
  • rearrangement reaction
    Àç¹è¿­ ¹ÝÀÀ(î¢ÛÕÖªÚãëë)
  • reversible reaction
    °¡¿ª ¹ÝÀÀ(Úãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
ITIL inter-alpha-trypsin inhibitor, light chain
LACS long chain acyl-coenzyme A synthetase
LCDD light chain deposition disease
LCFA long-chain fatty acid
L-cFA long chain fatty acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
PCR transcriptase)-polymerase chain reaction
PCR transcription-polymerase chain reaction
L-chain Light-chain
eIF Eukaryotic initiation factor
eIF-2 Eukaryotic initiation factor 2
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
reversible reaction A chemical reaction that takes place in either direction i.e., from the forward or reverse direction; ionization is such a reaction, as are reaction's involving racemases, isomerases, mutases, transferases, etc.
(05 Mar 2000)
graft-versus-host reaction <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
chemical reaction <chemistry> A process in which one or more substances are changed chemically into one or more different substances.
(09 Oct 1997)
periodic acid Schiff reaction <technique> A histochemical technique based on periodic acid oxidation of a substance containing the 1,2-glycol grouping.
It is used for staining carbohydrates as the resulting dialdehyde reacts with Schiff reagent to form a coloured product.
The adjacent hydroxyl groups are oxidized to form aldehydes by periodic acid (HIO4) and these aldehyde groups react with Schiff's reagent (basic fuchsin decolourised by sulphurous acid) to give a purple colour.
Acronym: PAS
(18 Nov 1997)
periosteal reaction <radiology> In adults: hypertrophic osteoarthropathy (HOA), pachydermoperiostosis, vascular insufficiency, thyroid acropachy, fluorosis in kids: physiologic periostosis, Caffey disease, JRA, acute leukaemia, scurvy, rickets, congenital syphilis, hypervitaminosis A
(12 Dec 1998)
periosteal reaction patterns <radiology> Pattern most indicative of buttressing eosinophilic granuloma laminated Ewing sarcoma or hair-on-end Codman triangle osteo- or chondrosarcoma or sunburst (per Resnick)
(12 Dec 1998)
peroxidase reaction Formation of indophenol blue by the action of an oxidizing enzyme present in certain cells and tissues when they are treated with a solution of alpha-naphthol and dimethylparaphenylenediamine; by this method, cells of the myelocyte series, which give a positive reaction, may be distinguished from those of the lymphocyte series, which give a negative reaction; endothelial leukocytes give a variable reaction, probably positive when they have phagocytised the debris of myeloid cells.
Synonym: Nadi reaction.
(05 Mar 2000)
group reaction A reaction with an agglutinin or other antibody that is common (though usually in varying concentrations) to an entire group of related bacteria, e.g., the coli group.
(05 Mar 2000)
Gruber's reaction Agglutination reaction as applied to the diagnosis of typhoid.
Synonym: Gruber's reaction, Gruber-Widal reaction.
(05 Mar 2000)
Gruber-Widal reaction Agglutination reaction as applied to the diagnosis of typhoid.
Synonym: Gruber's reaction, Gruber-Widal reaction.
(05 Mar 2000)
cholera-red reaction A test for cholera vibrio whereby the addition of 3 or 4 drops of sulfuric acid (concentrated, chemically pure) to an 18-hour-old bouillon or peptone culture of the organism produces a colour from rose-pink to claret.
(05 Mar 2000)
Gunning's reaction The formation of iodoform from acetone by iodine and ammonia in alcohol.
(05 Mar 2000)
chromaffin reaction Production of a yellow-brown to brown colouration in normal and abnormal cells containing epinephrine and norepinephrine, when fresh tissue slices are placed in a dichromate-chromate mixture overnight; useful for detection of pheochromocytoma (adrenal medulla) and other tumours which produce catecholamines.
(05 Mar 2000)
circular reaction In sensorimotor theory, the tendency of an organism to repeat novel experiences.
(05 Mar 2000)
phosphoroclastic reaction Cleavage of C-C bonds that involves phosphate transfer but not, as in phosphorolysis, directly to one of the products; e.g., the decomposition of pyruvate to acetate + CO2, in which Pi is added to ADP to form ATP.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á